Exchange Capital Management, Inc. Johnson & Johnson Transaction History

Exchange Capital Management, Inc.

$593 Million
Q3 2024

A detailed history of Exchange Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 17,275 shares of JNJ stock, worth $2.71 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

17,275

Previous 16,677 3.59%

Holding current value

$2.71 Million

Previous $2.44 Million 14.85%

% of portfolio

0.47%

Previous 0.41%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$145.48 - $167.38 $86,997 - $100,093	598 Added 3.59%	17,275 $2.8 Million
Q2 2024 Jul 23, 2024	BUY	$144.38 - $157.78 $90,237 - $98,612	625 Added 3.89%	16,677 $2.44 Million
Q1 2024 Apr 18, 2024	BUY	$155.22 - $162.74 $607,220 - $636,638	3,912 Added 32.22%	16,052 $2.54 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $26,936 - $29,392	-185 Reduced 1.5%	12,140 $1.9 Million
Q3 2023 Oct 30, 2023	SELL	$155.75 - $174.48 $2.51 Million - $2.81 Million	-16,094 Reduced 56.63%	12,325 $1.92 Million
Q2 2023 Jul 24, 2023	SELL	$154.35 - $166.11 $147,712 - $158,967	-957 Reduced 3.26%	28,419 $4.7 Million
Q1 2023 May 03, 2023	BUY	$151.05 - $180.26 $32,324 - $38,575	214 Added 0.73%	29,376 $4.55 Million
Q4 2022 Jan 31, 2023	SELL	$160.2 - $179.79 $156,195 - $175,295	-975 Reduced 3.24%	29,162 $5.15 Million
Q3 2022 Oct 31, 2022	SELL	$161.33 - $179.52 $247,964 - $275,922	-1,537 Reduced 4.85%	30,137 $4.92 Million
Q2 2022 Jul 28, 2022	SELL	$168.19 - $186.01 $292,818 - $323,843	-1,741 Reduced 5.21%	31,674 $5.62 Million
Q1 2022 Apr 28, 2022	SELL	$158.14 - $179.59 $92,986 - $105,598	-588 Reduced 1.73%	33,415 $5.92 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $32,901 - $36,505	-211 Reduced 0.62%	34,003 $5.82 Million
Q3 2021 Nov 01, 2021	SELL	$161.5 - $179.47 $219,640 - $244,079	-1,360 Reduced 3.82%	34,214 $5.53 Million
Q2 2021 Aug 05, 2021	SELL	$159.48 - $171.07 $56,615 - $60,729	-355 Reduced 0.99%	35,574 $5.86 Million
Q1 2021 May 10, 2021	SELL	$153.07 - $170.48 $75,004 - $83,535	-490 Reduced 1.35%	35,929 $5.91 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $466,174 - $535,092	3,400 Added 10.3%	36,419 $5.73 Million
Q3 2020 Nov 06, 2020	SELL	$140.38 - $153.83 $1,123 - $1,230	-8 Reduced 0.02%	33,019 $4.92 Million
Q2 2020 Aug 04, 2020	SELL	$128.81 - $155.51 $181,235 - $218,802	-1,407 Reduced 4.09%	33,027 $4.65 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $170,488 - $236,220	-1,534 Reduced 4.26%	34,434 $4.52 Million
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $282,795 - $324,803	-2,218 Reduced 5.81%	35,968 $5.25 Million
Q3 2019 Nov 07, 2019	SELL	$126.95 - $142.14 $16,122 - $18,051	-127 Reduced 0.33%	38,186 $4.94 Million
Q2 2019 Jul 22, 2019	BUY	$131.15 - $144.24 $2,229 - $2,452	17 Added 0.04%	38,313 $5.34 Million
Q1 2019 Apr 17, 2019	BUY	$125.72 - $139.79 $91,649 - $101,906	729 Added 1.94%	38,296 $5.35 Million
Q4 2018 Feb 01, 2019	BUY	$122.84 - $147.84 $34,763 - $41,838	283 Added 0.76%	37,567 $4.85 Million
Q3 2018 Oct 25, 2018	SELL	$121.58 - $142.88 $13,373 - $15,716	-110 Reduced 0.29%	37,284 $5.15 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $122,504 - $135,185	-1,026 Reduced 2.67%	37,394 $4.54 Million
Q1 2018 May 03, 2018	SELL	$125.1 - $148.14 $94,950 - $112,438	-759 Reduced 1.94%	38,420 $4.92 Million
Q4 2017 May 07, 2018	BUY	$131.22 - $143.62 $450,215 - $492,760	3,431 Added 9.6%	39,179 $5.47 Million
Q4 2017 Feb 05, 2018	SELL	$131.22 - $143.62 $641,665 - $702,301	-4,890 Reduced 12.03%	35,748 $5 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $5.26 Million - $5.5 Million	40,638	40,638 $5.28 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Johnson & Johnson Transaction History